Pharmalink Sp. z o. o. Revenue and Competitors
Estimated Revenue & Valuation
- Pharmalink Sp. z o. o.'s estimated annual revenue is currently $36.7M per year.
- Pharmalink Sp. z o. o.'s estimated revenue per employee is $328,000
Employee Data
- Pharmalink Sp. z o. o. has 112 Employees.
- Pharmalink Sp. z o. o. grew their employee count by 7% last year.
Pharmalink Sp. z o. o.'s People
Name | Title | Email/Phone |
---|
Pharmalink Sp. z o. o. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.4M | 112 | 18% | N/A | N/A |
#2 | $5.2M | 40 | 29% | N/A | N/A |
#3 | $6.3M | 48 | 26% | N/A | N/A |
#4 | $36.7M | 112 | 7% | N/A | N/A |
#5 | $5M | 38 | 73% | N/A | N/A |
What Is Pharmalink Sp. z o. o.?
Pharmalink jest wiodącym dostawcą rozwiązań logistycznych dla branży farmaceutycznej i weterynaryjnej. Specjalizujemy się w transporcie leków w warunkach pełnej kontroli temperatury. Nasze procesy, flota i procedury są zgodne z wymogami Prawa Farmaceutycznego i Dobrej Praktyki Dystrybucyjnej. To gwarantuje najwyższą jakość przechowywania, transportu i doręczenia farmaceutyków. Pharmalink to także nowoczesne hurtownie: farmaceutyczna i farmaceutyczna weterynaryjna, zapewniające zachowanie najwyższych standardów w farmacji. Pharmalink is Poland' leading provider of logistics solutions for pharmaceutical and veterinary industry. We specialise in transportation of medicines in fully temperature-controlled environment. Our processes, fleet and procedures meet the compliance of Pharmaceutical Law and Good Distribution Practice – GDP. That guarantees top standard of storage, transportation and delivery of pharmaceuticals.
keywords:N/AN/A
Total Funding
112
Number of Employees
$36.7M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.4M | 112 | 18% | N/A |
#2 | $22.7M | 113 | 8% | N/A |
#3 | N/A | 113 | 5% | N/A |
#4 | $14.3M | 119 | 17% | N/A |
#5 | N/A | 137 | 21% | N/A |